Canandaigua National Bank & Trust’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $701K | Buy |
+5,547
| New | +$731K | 0.06% | 208 |
|
|
2025
Q4 | $677K | Sell |
5,514
-142
| -3% | -$17.3K | 0.06% | 211 |
|
|
2025
Q3 | $628K | Sell |
5,656
-216
| -4% | -$24.6K | 0.06% | 225 |
|
|
2025
Q2 | $651K | Sell |
5,872
-100
| -2% | -$10.6K | 0.06% | 221 |
|
|
2025
Q1 | $669K | Buy |
5,972
+60
| +1% | +$6.19K | 0.07% | 216 |
|
|
2024
Q4 | $546K | Sell |
5,912
-83
| -1% | -$7.47K | 0.05% | 222 |
|
|
2024
Q3 | $503K | Sell |
5,995
-184
| -3% | -$14K | 0.05% | 226 |
|
|
2024
Q2 | $424K | Sell |
6,179
-3,100
| -33% | -$207K | 0.05% | 215 |
|
|
2024
Q1 | $680K | Buy |
9,279
+43
| +0.5% | +$3.31K | 0.1% | 163 |
|
|
2023
Q4 | $748K | Sell |
9,236
-50
| -0.5% | -$3.89K | 0.12% | 150 |
|
|
2023
Q3 | $696K | Sell |
9,286
-150
| -2% | -$11.5K | 0.11% | 152 |
|
|
2023
Q2 | $727K | Buy |
9,436
+51
| +0.5% | +$4.07K | 0.12% | 156 |
|
|
2023
Q1 | $779K | Buy |
+9,385
| New | +$777K | 0.13% | 151 |
|
|
2020
Q1 | $926K | Sell |
12,386
-1,828
| -13% | -$126K | 0.2% | 121 |
|
|
2019
Q4 | $924K | Sell |
14,214
-2,357
| -14% | -$153K | 0.16% | 137 |
|
|
2019
Q3 | $1.05M | Buy |
16,571
+2,842
| +21% | +$186K | 0.19% | 128 |
|
|
2019
Q2 | $928K | Sell |
13,729
-246
| -2% | -$16.2K | 0.17% | 129 |
|
|
2019
Q1 | $909K | Sell |
13,975
-3,347
| -19% | -$222K | 0.17% | 129 |
|
|
2018
Q4 | $1.08M | Sell |
17,322
-1,371
| -7% | -$95.8K | 0.23% | 114 |
|
|
2018
Q3 | $1.44M | Sell |
18,693
-150
| -0.8% | -$11.3K | 0.26% | 106 |
|
|
2018
Q2 | $1.33M | Sell |
18,843
-3,433
| -15% | -$242K | 0.26% | 105 |
|
|
2018
Q1 | $1.68M | Sell |
22,276
-10,374
| -32% | -$825K | 0.21% | 118 |
|
|
2017
Q4 | $2.34M | Sell |
32,650
-2,493
| -7% | -$189K | 0.42% | 65 |
|
|
2017
Q3 | $2.85M | Sell |
35,143
-243
| -0.7% | -$18.6K | 0.54% | 53 |
|
|
2017
Q2 | $2.5M | Sell |
35,386
-810
| -2% | -$53.9K | 0.51% | 55 |
|
|
2017
Q1 | $2.46M | Buy |
36,196
+9,482
| +35% | +$667K | 0.73% | 34 |
|
|
2016
Q4 | $1.91M | Sell |
26,714
-6,726
| -20% | -$500K | 0.57% | 46 |
|
|
2016
Q3 | $2.65M | Buy |
33,440
+1,273
| +4% | +$103K | 0.76% | 37 |
|
|
2016
Q2 | $2.68M | Sell |
32,167
-1,513
| -4% | -$134K | 0.76% | 35 |
|
|
2016
Q1 | $3.09M | Buy |
33,680
+3,827
| +13% | +$345K | 0.91% | 31 |
|
|
2015
Q4 | $3.02M | Buy |
29,853
+1,495
| +5% | +$156K | 0.92% | 33 |
|
|
2015
Q3 | $2.78M | Buy |
28,358
+1,818
| +7% | +$202K | 0.89% | 34 |
|
|
2015
Q2 | $3.11M | Buy |
26,540
+498
| +2% | +$54.4K | 0.91% | 31 |
|
|
2015
Q1 | $2.56M | Buy |
26,042
+70
| +0.3% | +$7.11K | 0.77% | 39 |
|
|
2014
Q4 | $2.45M | Buy |
25,972
+390
| +2% | +$40.3K | 0.78% | 38 |
|
|
2014
Q3 | $2.72M | Buy |
25,582
+11,037
| +76% | +$1.08M | 0.9% | 37 |
|
|
2014
Q2 | $1.21M | Sell |
14,545
-3,965
| -21% | -$309K | 0.4% | 64 |
|
|
2014
Q1 | $1.31M | Buy |
18,510
+1,530
| +9% | +$120K | 0.44% | 58 |
|
|
2013
Q4 | $1.27M | Buy |
16,980
+975
| +6% | +$67.9K | 0.45% | 55 |
|
|
2013
Q3 | $1.01M | Buy |
16,005
+2,216
| +16% | +$132K | 0.38% | 64 |
|
|
2013
Q2 | $707K | Buy |
+13,789
| New | +$719K | 0.28% | 83 |
|
Other funds holding GILD
Canandaigua National Bank & Trust's GILD Position: Q2 2026 in Review
Canandaigua National Bank & Trust opened a new position in Gilead Sciences (GILD) in Q2 2026: 5,547 shares worth $701K. The stake represents 0.06% of the portfolio and ranks #208 among its holdings. This is a return to the name: Canandaigua National Bank & Trust previously reported a position in GILD as recently as Q4 2025.
Canandaigua National Bank & Trust first reported a position in GILD in Q2 2013 and has held it in 41 quarters since. The position peaked at $3.11M in Q2 2015. 1,154 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Canandaigua National Bank & Trust held 5,547 shares of Gilead Sciences worth $701K as of Q2 2026.
- Gilead Sciences was a new Canandaigua National Bank & Trust position in Q2 2026.
- Gilead Sciences made up 0.06% of Canandaigua National Bank & Trust's portfolio in Q2 2026, its #208 holding.
- Canandaigua National Bank & Trust first reported a position in Gilead Sciences in Q2 2013 and has held it in 41 quarters since.
- Canandaigua National Bank & Trust's Gilead Sciences position peaked at $3.11M in Q2 2015.
- 1,154 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Canandaigua National Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.